Stock MYL MYLAN N.V.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Mylan N.V. Nasdaq

Equities

MYL

NL0011031208

Chart calendar Mylan N.V.

6c4d8d8f8584a3aca1.EeV0u_3kwPk1j9374URrczmPO6u1hoZ2s6J-8OsvOWs.Kb8niIidjNQE7pehszxTHFfqFu-GtMc84eYct51GaA98sjOKy7y2jHHjug~a6a9b3f9ab4cf61fcb77f068476292c1

Upcoming events on Mylan N.V.

09/05/2024 Q1 2024 Earnings Release Pre-market
09/05/2024 06:00 pm Q1 2024 Earnings Call
05/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Mylan N.V.

27/03/2024 07:30 pm R&D Day
08/03/2024 Ex-dividend day
28/02/2024 07:00 pm Q4 2023 Earnings Call
28/02/2024 05:00 pm Q4 2023 Earnings Release
11/01/2024 12:00 am JPMorgan Healthcare Conference
15/12/2023 09:30 pm Annual General Meeting
22/11/2023 Ex-dividend day
15/11/2023 03:00 pm Jefferies London Healthcare Conference
08/11/2023 03:30 am Q3 2023 Earnings Call
08/11/2023 02:32 am Q3 2023 Earnings Release
23/08/2023 Ex-dividend day
07/08/2023 06:00 pm Q2 2023 Earnings Call
07/08/2023 04:29 pm Q2 2023 Earnings Release
14/06/2023 01:50 am Goldman Sachs Global Healthcare Conference
23/05/2023 Ex-dividend day
08/05/2023 06:00 pm Q1 2023 Earnings Call
08/05/2023 04:29 pm Q1 2023 Earnings Release
25/04/2023 03:00 am American Academy of Neurology Meeting - Poster #014
08/03/2023 Ex-dividend day
27/02/2023 07:00 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		11 501
11 537
-0.32%		11 946
12 273
-2.66%		17 886
17 881
0.03%		16 263
16 372
-0.67%		15 427
15 465
-0.25%
15 219

EBITDA
Million USD		Released
Forecast
Spread 		3 540
3 500
1.12%		3 654
4 483
-18.49%		6 426
6 464
-0.59%		5 777
5 852
-1.29%		5 124
5 197
-1.4%
4 885

EBIT
Million USD		Released
Forecast
Spread 		3 264
3 212
1.62%		3 376
3 864
-12.61%		6 046
6 111
-1.07%		5 475
5 566
-1.62%		4 725
4 851
-2.6%
4 570

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		154
807
-80.87%		-721
3 677
-119.61%		-664
-580
-14.55%		2 813
878
220.41%		203
1 198
-83.06%
4 100

Net income
Million USD		Released
Forecast
Spread 		16,8
427
-96.07%		-670
1 449
-146.24%		-1 269
-952
-33.29%		2 079
1 328
56.46%		54,7
812
-93.26%
1 885

EPS
USD		Released
Forecast
Spread 		0,03
0,81
-96.3%		-1,11
1,62
-168.59%		-1,05
-0,77
-36.36%		1,71
1,01
69.62%		0,05
0,84
-94.02%
1,45

Announcement Date27/02/2001/03/2128/02/2227/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		4 342
4 337
0.11%		4 192
4 258
-1.55%		4 117
4 185
-1.62%		4 078
4 136
-1.39%		3 876
3 988
-2.8%		3 729
3 812
-2.18%		3 919
3 862
1.45%		3 942
3 997
-1.37%		3 837
3 877
-1.03%
3 707


3 830


3 908


3 896


3 821

EBITDA
Million USD		Released
Forecast
Spread 		1 416
1 481
-4.39%		1 586
1 445
9.8%		1 482
1 443
2.73%		1 498
1 431
4.69%		1 211
1 288
-6%		1 341
1 222
9.69%		1 306
1 255
4.04%		1 360
1 293
5.2%		1 117
1 220
-8.44%
1 247


1 188


1 258


1 195




EBIT
Million USD		Released
Forecast
Spread 		1 314
1 383
-5.04%		1 551
1 375
12.82%		1 425
1 375
3.57%		1 415
1 368
3.4%		1 085
1 166
-6.96%		1 255
1 151
9.02%		1 226
1 178
4.12%		1 257
1 208
4.05%		987
1 100
-10.29%
1 101


1 139


1 191


1 125


1 131

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-204
-119
-71.34%		528
48,0
998.96%














402
260
54.69%		-855
140
-710.71%














Net income
Million USD		Released
Forecast
Spread 		-264
53,2
-595.86%		399
149
167.56%		314
234
34.21%		354
357
-0.78%		1 011
257
292.86%		225
154
46.31%		264
225
17.13%		332
246
35.03%		-766
114
-771.58%
123


144


188


188




EPS
USD		Released
Forecast
Spread 		-0,22
0,41
-154.32%		0,33
0,08
304.11%		0,26
0,19
36.43%		0,29
0,42
-31.07%		0,83
0,15
453%		0,19
0,23
-15.82%		0,22
0,20
8.2%		0,27
0,34
-20.08%		-0,64
0,26
-344.8%
0,12


0,14


0,23


0,30




Announcement Date28/02/2209/05/2208/08/2207/11/2227/02/2308/05/2307/08/2307/11/2328/02/24-----

Upcoming sector events for Mylan N.V.

29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
29/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
29/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Mylan N.V.

27/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
27/04/2024 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
27/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
27/04/2024 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
27/04/2024 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
27/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
27/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
27/04/2024 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
27/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
27/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. VTRS Stock
  4. MYL Stock
  5. Calendar Mylan N.V.